TFX — Teleflex Incorporated

Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE. It is led by Stuart A. Randle, based in 550 East Swedesford Road, Wayne, PA, United States, 19087-1603, with about 15,500 employees. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Latest reported TFX revenue for 2025-09-28 was $913.0M. Net income was -$408.9M. Revenue was up 16.9% from 2025-06-29 to 2025-09-28. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.

Use this TFX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TFX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TFX SEC filings page. Lician reads the product cache first so this HTML stays unique to Teleflex Incorporated even when a live quote feed is slow.